February 1, 2018Open Access

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study

Key Points

Key points are not available for this paper at this time.

Abstract

Ipragliflozin was effective in non-elderly and elderly Japanese T2DM patients in a real-world clinical setting. The incidence of renal disorder and skin complications was significantly higher in elderly vs. non-elderly patients.

KI fragen

Bookmark

View Full Paper

Cite This Study

Maegawa et al. (Thu,) studied this question.

synapsesocial.com/papers/69da1fb58988aeabbe686796 https://doi.org/https://doi.org/10.1080/14656566.2018.1434145

KI fragen

Bookmark

View Full Paper